Company / Total Debt
Omnicell Total Debt History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$50.0M
FY2019
5-year range
-
FY2016-FY2019
Trend
-64.3%
vs FY2018
Sector context
#92 of 100
Health Care
What the data says
Among 100 Health Care companies, Omnicell is in the top 8% for total debt. Total Debt has declined for 3 consecutive years, from $246M in FY2016 to $50M in FY2019.
Based on SEC 10-K filings.
$50M in FY2019 with a 3-year CAGR of -41.2%.
Improved from $195M to $50M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -41.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 100This company $50.0M Sector average $4.6B
▼
-98.9% below sector average
Key checks
Key Insights
- Omnicell's total debt has declined for 3 consecutive years.
- 3-year CAGR of -41.2%, indicating a declining trend.
- In FY2019, total debt decreased 64.3% year-over-year.
- Ranks #92 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $50.0M | -64.3% |
| FY2018 | $140.0M | -28.2% |
| FY2017 | $194.9M | -20.7% |
| FY2016 | $245.7M | - |
As of FY2019 · SEC 10-K · Updated Jun 30, 2026